Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
M. Sekip Altunkan: The Thrombotic Risk of Andexanet Alfa
Nov 19, 2026, 13:26

M. Sekip Altunkan: The Thrombotic Risk of Andexanet Alfa

M. Sekip Altunkan, Associate Professor and Internal Medicine Specialist at a Private Medical Practice, shared a post on LinkedIn:

“When the antidote that halts a fatal bleed triggers a secondary catastrophe.

Targeted reversal with andexanet alfa rapidly arrests factor Xa inhibitor-associated hemorrhage, yet clinicians often underestimate the prothrombotic rebound created by TFPI inhibition colliding with a vulnerable vascular bed.

A new pooled analysis of the ANNEXA-I and ANNEXA-4 cohorts uncovers a distinct temporal split between early arterial clots and late venous events—identifying the exact patient subgroups facing the steepest mortality penalty and how anticoagulation resumption shifts the balance.”

Stay updated with Hemostasis Today.